Bright Green Corporation Future May be Getting Brighter Shares of Bright Green Corporation have moved sharply higher after the company announced a funding agreement, but this penny stock may still carry some risk

By Chris Markoch

This story originally appeared on MarketBeat

The Future for Bright Green Corporation May be Getting Brighter

Bright Green Corporation (NASDAQ: BGXX) teaches investors the risk and rewards of investing in penny stocks. On February 1, BGXX stock shot up 170% after the company announced plans to raise $500 million as part of the U.S. Citizenship and Immigration Services EB-5 capital program.  

However, the stock has dropped approximately 41% from its February 1 peak when the market closed on February 2. Nevertheless, BGXX stock has rewarded investors with a gain of over 129% in the year's first month.  

And, with the recent market rally pulling some speculative money off the sidelines, there’s reason to believe that penny stocks like Bright Green may have higher to go. At the same time, many penny stocks are priced that way for a reason. In this article, we’ll look at the bright future for Bright Green Corporation.  

Flexing Its Competitive Advantage 

The company will use the funds to create over 7,100 jobs in the United States. Bright Green plans to improve its production facilities in its home state of New Mexico. And it will also support drug research, development and FDA clinical trials.  

Investors cheered this announcement that the company could raise capital without tapping equity or debt markets. One reason the company can do this is due to the competitive advantage that Bright Green has in relation to the rest of the cannabis market.  

One of the headwinds affecting virtually every cannabis stock is that cannabis is still considered a banned substance at the Federal level. No matter how many states approve medicinal and/or recreational marijuana, doing business across state borders is impossible. And even multi-state operators must navigate state laws that, in many cases, lack consistency.  

This is where Bright Green offers a competitive advantage. Specifically, the company has a Memorandum of Agreement (MOA) with the U.S. Drug Enforcement Association. Among other things, the MOA allows Bright Green “to fund its growth, business, and operations by seeking capital from U.S. public capital markets, as well as traditional U.S. commercial financing sources.” 

The MOA also allows Bright Green to register with the DEA to be a bulk manufacturer of cannabis and derivatives for producing FDA-approved commercial products that result from medicinal research.  

And according to the company’s website, all of this positions BGC “to become a leading U.S. player in the manufacturing of cannabis and derivatives for FDA-approved medicinal products, opening up opportunities for joint ventures with large pharmaceutical players.” 

Penny Stocks are Still Penny Stocks 

The sharp sell-off in BGXX stock the day after its 170% rally to the upside reminds you of the challenges involved when you invest in penny stocks. Bright Green is not profitable but is still a pre-revenue company.  

That could be changing. The company is projecting its latest move will eventually lead to $500 million in revenue. But moves like this should make investors attentive to short-selling activity. As evidence of this, because it dropped more than 10% in the trading session, BGXX triggered the Securities & Exchange Commission’s (SEC) uptick rule. Simply put, this prevents short sellers from pushing the shares of a company lower.

Wavy Line

Editor's Pick

'Catastrophic': Here's What You Should Know About the Debt Ceiling Crisis — And How a Default Could Impact Your Business
I Helped Grow 4 Unicorns Over 10 Years That Generated $18 Billion in Online Revenues. Here's What I've Learned.
Want to Break Bad Habits and Supercharge Your Business? Use This Technique.
Don't Have Any Clients But Need Customer Testimonials? Follow These 3 Tricks To Boost Your Rep.
Why Are Some Wines More Expensive Than Others? A Top Winemaker Gives a Full-Bodied Explanation.

Related Topics

Business News

7 of the 10 Most Expensive Cities to Live in the U.S. Are in One State

A new report by U.S. News found that San Diego is the most expensive city to live in for 2023-2024, followed by Los Angeles. New York City didn't even rank in the top 10.

Money & Finance

3 Ways to Create Multiple (Big) Streams of Income

Here are three ways to create multiple streams of income. These strategies require effort and resources but offer significant financial potential.

Science & Technology

She's Been Coding Since Age 7 and Presented Her Life-Saving App to Tim Cook Last Year. Now 17, She's on Track to Solve Even Bigger Problems.

Angelina Tsuboi, a full-stack mobile and web developer who also happens to be a pilot, has always been solution-oriented.


Beyond Marketing — How Brands Can Truly Support the Black Community on Juneteenth

Here are a few authentic ways businesses can support and serve as allies to the Black community on Juneteenth.


The Real Reason Why The Return to Office Movement is Failing is Revealed in New Study

There is a vivid sign of the disconnect between employees and their workplace, a glaring indication that companies need to revise their scripts to improve their hybrid and remote work policies.